Ventas, Inc. $VTR Holdings Trimmed by Handelsbanken Fonder AB

Handelsbanken Fonder AB lowered its holdings in Ventas, Inc. (NYSE:VTR) by 12.0% in the fourth quarter, Holdings Channel.com reports. The firm owned 241,779 shares of the real estate investment trust’s stock after selling 33,007 shares during the period. Handelsbanken Fonder AB’s holdings in Ventas were worth $18,709,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Bridgewater Advisors Inc. grew its holdings in shares of Ventas by 2.0% during the fourth quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock valued at $525,000 after buying an additional 133 shares in the last quarter. Arbor Capital Management Inc. ADV boosted its position in Ventas by 0.6% during the 3rd quarter. Arbor Capital Management Inc. ADV now owns 21,716 shares of the real estate investment trust’s stock worth $1,520,000 after acquiring an additional 137 shares during the period. True Wealth Design LLC grew its stake in Ventas by 32.0% during the 4th quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after acquiring an additional 138 shares in the last quarter. Cigna Investments Inc. New increased its holdings in shares of Ventas by 3.3% in the 4th quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock valued at $341,000 after purchasing an additional 142 shares during the period. Finally, Foundations Investment Advisors LLC lifted its position in shares of Ventas by 3.3% in the third quarter. Foundations Investment Advisors LLC now owns 4,447 shares of the real estate investment trust’s stock worth $311,000 after purchasing an additional 144 shares in the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Stock Performance

Shares of VTR opened at $88.65 on Thursday. The company’s fifty day moving average is $85.23 and its 200-day moving average is $81.68. Ventas, Inc. has a 12 month low of $61.76 and a 12 month high of $91.06. The firm has a market cap of $43.10 billion, a price-to-earnings ratio of 161.19, a price-to-earnings-growth ratio of 2.17 and a beta of 0.74. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95.

Ventas (NYSE:VTR) last released its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm’s revenue for the quarter was up 22.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Equities analysts expect that Ventas, Inc. will post 3.86 EPS for the current fiscal year.

Ventas Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be given a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.3%. Ventas’s payout ratio is currently 378.18%.

Insider Activity

In related news, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the transaction, the director directly owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.53% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $93.00 price objective on shares of Ventas in a research report on Monday, February 9th. Royal Bank Of Canada upped their price target on shares of Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a research note on Monday, May 4th. Mizuho increased their price objective on Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, March 4th. Evercore restated an “outperform” rating and issued a $95.00 target price on shares of Ventas in a research note on Wednesday, April 29th. Finally, UBS Group upped their target price on Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research report on Monday, May 4th. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $94.63.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.